{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:57:26Z","timestamp":1697612246103},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":2735,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Physiology"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p>Coronary artery disease (CAD) has been reported to occur prematurely in individuals with spinal cord injury (SCI). Although persons with SCI have metabolic abnormalities that may predispose them to CAD, other potential aetiologies may also be operative. Increased platelet aggregation, among other factors, initiates thrombus formation at the site of the vessel injury, which may acutely obstruct arterial blood flow. Prostacyclin is known to have a beneficial effect to inhibit platelet aggregation and prevent thrombus formation. Platelets were studied from 12 pairs of monozygotic twins, one co\u2010twin with SCI. Each twin pair had similar patterns of platelet aggregation with adenosine diphosphate (ADP), thrombin or collagen, as well as inhibition of platelet aggregation by prostacyclin (PGE<jats:sub>1<\/jats:sub>\/I<jats:sub>2<\/jats:sub>) and synthesis of cyclic adenosine mono phosphate (AMP) by the prostanoid. However, the twin pairs differed in their response to PGE<jats:sub>1<\/jats:sub>\/I<jats:sub>2<\/jats:sub> inhibition of platelet\u2010stimulated thrombin generation that was completely inhibited in non\u2010SCI platelets but not in SCI platelets. Scatchard analysis of the binding of <jats:sup>3<\/jats:sup>H\u2010prostaglandin E<jats:sub>1<\/jats:sub>, a stable prostacyclin receptor probe, showed the presence of one high\u2010affinity (<jats:italic>K<\/jats:italic><jats:sub>d1<\/jats:sub>=8\u00b71\u2003\u00b1\u20032\u00b78\u2003n<jats:sc>M<\/jats:sc>; <jats:italic>n<\/jats:italic><jats:sub>l<\/jats:sub>=168\u2003\u00b1\u200335 sites per platelet) and one low\u2010affinity (<jats:italic>K<\/jats:italic><jats:sub>d2<\/jats:sub>=1\u00b71\u2003\u00b1\u20030\u00b722\u2003\u03bc<jats:sc>M<\/jats:sc>; <jats:italic>n<\/jats:italic><jats:sub>2<\/jats:sub>=1772\u2003\u00b1\u2003220 sites per cell) prostacyclin receptor in normal platelets, whereas in SCI platelets there was a significant loss (<jats:italic>P<\/jats:italic>&lt;0\u00b700l) of high\u2010affinity receptor sites (<jats:italic>K<\/jats:italic><jats:sub>d1<\/jats:sub>=6\u00b734\u2003\u00b1\u20031\u00b780\u2003n<jats:sc>M<\/jats:sc>; <jats:italic>n<\/jats:italic><jats:sub>1<\/jats:sub>=42\u2003\u00b1\u200311 sites per platelet) with no significant change in the low\u2010affinity receptor sites (<jats:italic>K<\/jats:italic><jats:sub>d2<\/jats:sub>=1\u00b72\u2003\u00b1\u20030\u00b723\u2003\u03bc<jats:sc>M<\/jats:sc>; <jats:italic>n<\/jats:italic><jats:sub>2<\/jats:sub>=1860\u2003\u00b1\u2003412 sites per cell). These discordant platelet findings in identical twin pairs raises the possibility of an environmental aetiology for accelerated CAD in those with SCI. The loss of inhibitory effect of PGI<jats:sub>2<\/jats:sub> on thrombin generation in the twin with SCI appears to be because of loss of platelet high\u2010affinity prostanoid receptors, which may contribute to atherogenesis in individuals with SCI.<\/jats:p>","DOI":"10.1046\/j.1365-2281.2001.00301.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:35:49Z","timestamp":1047389749000},"page":"60-66","source":"Crossref","is-referenced-by-count":1,"title":["Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury"],"prefix":"10.1046","volume":"21","author":[{"given":"Nighat N.","family":"Kahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asru K.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3100911"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb17087.x"},{"key":"e_1_2_5_4_1","unstructured":"ColmanR. W. MarderV. J. SalzmanE. W. HirchJ.(1987)Overview of hemostasis and thrombosis. In:Hemostasis and Thrombosis(eds Colman R. W. Hirch J. Marder V. J. & Salzman E. W.) pp. 13\u201317. Lippincott Philadelphia PA."},{"key":"e_1_2_5_5_1","first-page":"314S","article-title":"Cellular mechanism of atheriogenesis","volume":"11","author":"DiCOrleto P. E.","year":"1993","journal-title":"Am J Hypertens"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"12685","DOI":"10.1016\/S0021-9258(18)45261-1","article-title":"Purification and properties of prostaglandin El\/prostacyclin receptor of human blood platelets","volume":"262","author":"Dutta\u2010ROy A. K.","year":"1987","journal-title":"J Biol Chem"},{"key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"C236","DOI":"10.1152\/ajpcell.1994.267.1.C236","article-title":"Regulation of calcium mobilization and entry in human platelets by endothelial\u2010derived factors","volume":"267","author":"Gieger J.","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.67.1.305"},{"key":"e_1_2_5_9_1","unstructured":"HalbruggeJ. W.&WalterU.(1993)The regulation of platelet function by protein kinases. In:Protein Kinases in Blood Cell Function(eds Huang C. K. & Sha\u2019afi R. I.) pp. 245\u2013298. CRC Boca Raton FL."},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470720172.ch7"},{"key":"e_1_2_5_11_1","unstructured":"HolmsenH.(1987)Platelet secretion. In:Hemostasis and Thrombosis(eds Colman R. Hirch W. J. Marder V. J. & Salzman E. W.) pp. 804\u2013815. Lippincott Philadelphia PA."},{"key":"e_1_2_5_12_1","unstructured":"HougieC.(1972)Euglobulin lysis time. In:Hematology(eds Williams W. J. Buetler E. Erslev J. & Rundles R. W.) pp. 1642\u20131645. McGraw\u2010Hill New York."},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80037-7"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(92)90158-I"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1999.276.5.E856"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8779"},{"key":"e_1_2_5_17_1","first-page":"H117","article-title":"Insulin\u2010induced release of plasminogen activator from human blood platelets","volume":"268","author":"Kahn N. N.","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_5_18_1","first-page":"H2160","article-title":"Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans","volume":"265","author":"Kahn N. N.","year":"1993","journal-title":"Am J Physiol"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.68.1.245"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1016\/S0021-9258(19)34071-2","article-title":"Stimulation of prostaglandin E1 binding to human platelet membrane by insulin and the activation of adenylate cyclase","volume":"265","author":"Kahn N. N.","year":"1990","journal-title":"J Biol Chem"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.66.4.932"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(88)90101-2"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.59.1.8"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.2.630"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.7.6.8472890"},{"key":"e_1_2_5_26_1","first-page":"109","article-title":"Nitric oxide\u2010physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada S.","year":"1991","journal-title":"Pharmacol Rev"},{"key":"e_1_2_5_27_1","unstructured":"MustardJ. F. Kinlough\u2010RAthboneR. J. PackmanM. A.(1987)The vessel wall in thrombosis. In:Hemostasis and Thrombosis(eds Colman R. W. Hirch J. Marder V. J. & Salzman E. W.) pp. 1073\u20131088. Lippincott Philadelphia PA."},{"key":"e_1_2_5_28_1","first-page":"1","article-title":"Reduction in prostacyclin platelet receptors in active spontaneous angina","volume":"2","author":"Neri SErneri G. G.","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_5_29_1","first-page":"l","article-title":"The role of calcium antagonists in the treatment of atherosclerosis and hypertension","volume":"16","author":"Ouchi Y.","year":"1990","journal-title":"J Cardovasc Pharmacol"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.52.030190.002243"},{"key":"e_1_2_5_31_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atheriosclerosis\u2010a perspective study for the 1990s","volume":"363","author":"Ross R.","year":"1993","journal-title":"Nature (London)"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116685"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1993.00540090018005"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1949.tb27297.x"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109292"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230106"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104130"}],"container-title":["Clinical Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2281.2001.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2281.2001.00301.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2281.2001.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:28:14Z","timestamp":1697578094000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2281.2001.00301.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1365-2281.2001.00301.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2281.2001.00301.x","archive":["Portico"],"relation":{},"ISSN":["0144-5979","1365-2281"],"issn-type":[{"value":"0144-5979","type":"print"},{"value":"1365-2281","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}